Genomic Health Announces Study Results Demonstrating Oncotype DX 's Ability to Quantify Risk for Local and Regional Breast Cancer Recurrence
12th Dec 2005, 13:04 GMT
Three Studies Presented at the 28th Annual San Antonio Breast CancerSymposium Add to Body of Clinical Evidence Which Support the Clinical Utility of Oncotype DX in Early Breast Cancer
Genomic Health Announces Study Results Demonstrating Oncotype DX 's Ability to Quantify Risk for Local and Regional Breast Cancer Recurrence related news:
- New External Study Demonstrates Strong Correlation of TriPath Imaging's ProEx Br Biomarkers with Risk of Breast Cancer Recurrence — FDA News News from StratCenter.com
- Radiotherapy aids breast cancer survival: study (Reuters) — Yahoo! News: Health News
- Radiotherapy aids breast cancer survival: study — Reuters: Health
- Radiotherapy aids breast cancer survival — MSNBC.com: Health
- Radiotherapy aids breast cancer survival - study — KeralaNext: International
- SABCS: Shorter Chemotherapy Regimen Plus Taxol Reduces Breast Cancer Recurrence — MedPage Today Hematology/Oncology
- Women With Breast Cancer Risk Developing Other Cancers — VOA News: Health
- VOA Health Brief 5:1 Women With Breast Cancer Risk Developing Other Cancers — VOA News: United States
- Low-Fat Dairy May Cut Postmenopausal Breast Cancer Risk — WOODTV - Health
- Two year wait for women at risk of breast cancer — the Mail online | Home
Latest news from Surgery News from StratCenter.com:
- Technology Making LASIK Safer for Those Who Have Had Previous Eye Surgery
- Symbion to Participate in Credit Suisse Phoenix Healthcare Conference
- Sustained Response at Month 12 for Transgene's TG 4001 in HPV-Induced Precancerous Lesions of the Cervix and Next Clinical Development Steps
- Experts: Laser Eye Surgery Safe
- Survey Says: Women Love Botox Almost as Much as Paris
- Cardiogenesis Reports Q3 2006 Results
- SOLX Establishes Int'l Certification Program
- Encision Secures $2 mln Line of Credit Facility
- South Broward Hospital District Board Approves Purchase Agreement for Hollywood Med Cntr
- Beyond Bifocals: Data Shows Wavefront Technology Benefits Patients With Presbyopia